InMed Pharmaceuticals Inc. INM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.23M | 5.20M | 7.00M | 9.37M | 10.79M |
| Total Receivables | -- | -- | 183.00K | 343.50K | -- |
| Inventory | -- | -- | 947.90K | 890.80K | -- |
| Prepaid Expenses | 241.30K | 617.20K | 660.30K | 191.80K | 319.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 201.30K | 1.07M | -- | -- | 1.76M |
| Total Current Assets | 2.68M | 6.89M | 8.79M | 10.80M | 12.87M |
|
|
|||||
| Total Current Assets | 2.68M | 6.89M | 8.79M | 10.80M | 12.87M |
| Net Property, Plant & Equipment | 221.00K | 642.90K | 764.30K | 881.50K | 992.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 1.50M | 1.54M | 1.58M | 1.62M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 132.30K | 104.40K | 100.00K | 100.00K | 100.00K |
| Total Assets | 3.03M | 9.13M | 11.19M | 13.36M | 15.58M |
|
|
|||||
| Total Accounts Payable | 927.20K | 225.10K | 166.80K | 369.10K | 277.90K |
| Total Accrued Expenses | 916.20K | 786.50K | 697.70K | 592.30K | 953.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 389.40K | 408.10K | 424.80K | 435.50K |
| Total Finance Division Other Current Liabilities | 111.70K | 810.30K | 207.40K | 168.80K | 173.40K |
| Total Other Current Liabilities | 111.70K | 810.30K | 207.40K | 168.80K | 173.40K |
| Total Current Liabilities | 1.96M | 2.21M | 1.48M | 1.56M | 1.84M |
|
|
|||||
| Total Current Liabilities | 1.96M | 2.21M | 1.48M | 1.56M | 1.84M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 30.80K | 123.80K | 215.50K | 305.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.96M | 2.24M | 1.60M | 1.77M | 2.15M |
|
|
|||||
| Common Stock & APIC | 131.18M | 130.72M | 130.45M | 130.43M | 130.54M |
| Retained Earnings | -130.23M | -123.96M | -120.99M | -118.96M | -117.24M |
| Treasury Stock & Other | 128.60K | 128.60K | 128.60K | 128.60K | 128.60K |
| Total Common Equity | 1.08M | 6.89M | 9.59M | 11.59M | 13.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.08M | 6.89M | 9.59M | 11.59M | 13.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.08M | 6.89M | 9.59M | 11.59M | 13.43M |
|
|
|||||